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Background: The aim was to study the glycaemic control of type 2 diabetic patients, and to identify factors
associated with unacceptable glycaemic control (defined as HbA1c >8.0%).
Methods: Analysis of data collected in a cross-sectional survey of type 2 diabetic patients in eight SingHealth
Polyclinics in January 2009. HbA1c value was measured on the day of the survey, while information on patient and
diabetic characteristics was obtained through a questionnaire. Odds ratio of having unacceptable glycaemic control
was estimated for selected variables using multiple logistic regression models.
Results: A total of 688 patients were included in the analysis. The mean (± standard deviation) and median (range)
HbA1c levels were 7.6% (± 1.35) and 7.3% (5.0% to 14.0%), respectively. 25.4% of the patients had an unacceptable
HbA1c level of >8.0% and the odds of this were higher (p < 0.05) in patients with the following characteristics:
younger age, longer diabetes duration, presence of insulin treatment, and poorer compliance to medication.
Conclusion: Younger adult patients were found to have poorer glycaemic control, and hence targeted educational
and behaviour modification programmes would be required to effectively manage this group of patients.
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Type 2 diabetes mellitus is now a major chronic disease
epidemic. An estimated 285 million people worldwide
were affected in 2010 [1], with 1.3 million deaths due to
diabetes [2].
Type 2 diabetes mellitus causes significant mortality and
morbidity [3] due to its long-term micro-vascular and
macro-vascular complications, and these adverse out-
comes are associated with poorer glycaemic control [4].
Each 1% reduction in updated mean HbA1c has been
shown to be associated with reduction in risk of 21% for
deaths related to diabetes, 14% for myocardial infarction,
and 37% for microvascular complications [5]. Despite clin-
ical evidence of the beneficial effect of glycaemic control
and the advances achieved in diabetes control and treat-
ment, the management of type 2 diabetes mellitus remains* Correspondence: joanne.quah.h.m@singhealth.com.sg
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reproduction in any medium, provided the orchallenging. Data from different regions of the world show
that the majority of patients with type 2 diabetes mellitus
are not controlled to the recommended HbA1c level [6,7].
There is also increasing recognition that intensive (ver-
sus conventional) glucose lowering treatment has limited
benefits on all-cause mortality and deaths from cardio-
vascular causes, and the harm associated with severe
hypoglycemia might counter balance the potential bene-
fit of intensive glucose lowering treatment [8]. This sug-
gests that glucose-lowering regimens should be tailored
to the individual patient.
With rapid urbanization development in the past few
decades, Singapore has emerged a country with high
prevalence of diabetes mellitus. From 2004 to 2010, the
percentage of Singapore residents with diabetes aged 18 to
69 years old has increased from 8.2% to 11.3%. [9]. Dia-
betes was the 10th leading cause of death in 2009 and
contributed to 1.7% of all deaths locally [10]. Using the
Singapore Diabetes Mellitus Clinical Practice Guidelines
[11], the HbA1c value has been classified into fourtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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optimal: 7.1% to 8%; and unacceptable: >8%. In our study,
we used the cut off value of >8% to identify patients with
unacceptable glycaemic control.
In Singapore, the majority of patients with type 2 dia-
betes mellitus are treated in the primary health care set-
ting. SingHealth Polyclinics is a group of 9 public primary
care polyclinics serving the central and eastern parts of
Singapore. In 2010, SingHealth Polyclinics had a total of
1.746 million medical patient attendances, 7.7% of these
attendances were for diabetes mellitus, and we currently
have 55,000 active patients in our diabetes database.
Information on glycaemic control of the patients in the
polyclinics is of great value for planning diabetes manage-
ment programs to prevent and delay the onset of chronic
complications. The aim of our study was to 1) investigate
the prevalence of suboptimal glycaemic control and 2)
identify factors associated with unacceptable glycaemic
control in type 2 diabetes mellitus patients treated and
followed up in SingHealth polyclinics.
Methods
Study design
We conducted a cross-sectional survey in eight
SingHealth Polyclinics, including Bedok, Bukit Merah,
Geylang, Outram, Pasir Ris, Queenstown, Sengkang, and
Tampines Polyclinics, which are located in the residential
areas in Singapore. Results are from the analysis of data
collected by third year medical students from Yong Loo
Lin School of Medicine, National University of Singapore
conducting a Community Health Project in January 2009.
The study objectives were to study glycaemic control, as
well as health-related quality of life of type 2 diabetic pa-
tients treated in SingHealth Polyclinics which was previ-
ously reported [12].
Systematic sampling was used to recruit the partici-
pants. During the study period, recruiters were stationed
at the clinical laboratory of the polyclinics, and all pa-
tients coming to the laboratory were approached. All
type 2 diabetic patients above 21 years of age on follow-
up at SingHealth Polyclinics who had the glycosylated
haemoglobin (HbA1c) test on the day of survey as part
of their routine 3-monthly visit, and who were able to
communicate to give informed consent were identified.
Every other eligible type 2 diabetic patient was invited to
participate in the study.
An interviewer-administered questionnaire was conduc-
ted after written consent was obtained. Patients compe-
tent in the English, Chinese, or Malay were also given the
option to self-administer the questionnaire survey. In the
event that the patient was illiterate and was not able to
communicate well with the interviewer, his or her care-
giver would be the administrator. The patients were aware
that they were free to terminate their participation at anypoint of time through the conduct of the survey. This
study was approved by the Institutional Review Board of
SingHealth Polyclinics.
Statistical analysis
All statistical analyses were conducted using SPSS version
17.0. The HbA1c value was the dependent variable in data
analyses. The value of HbA1c was taken from the test re-
sult and is a continuous variable, and analysed as a binary
outcome (greater than 8% vs less than/equal to 8%). All
other variables were categorical data, for example, age was
coded as three groups: <60 years old, 60–69 years old, and
70 years and above. The statistical analyses included both
descriptive and association analyses. The descriptive ana-
lysis was conducted for demographic, socio-economic and
diabetic disease characteristics. Association analysis of
possible predictors for unacceptable glycaemic control
was conducted in two steps. First, bivariate logistic regres-
sion was performed for each variable to examine un-
adjusted association with unacceptable HbA1c control;
second, variables which were identified to be significantly
(p < 0.05) associated with the unacceptable HbA1c control
in the bivariate analysis were included in a multivariate lo-
gistic regression model for assessing adjusted effects of
predictors on poor HbA1c control. Age, gender and ethni-
city were also included in this multivariate logistic regres-
sion model as independent variables.
Results
Patient recruitment
Using a systematic sampling method, a total of 699 sub-
jects participated in our study, representing a response
rate of 72.5%. Of this, 688 had valid HbA1c values and
were included in the final data analysis.
Distribution of HbA1c level
The mean (±standard deviation) and median (range)
HbA1c level was 7.6% (±1.35) and 7.3% (5.0% to 14.0%),
respectively. Using the Singapore Diabetes Mellitus Clin-
ical Practice Guidelines 2006 [11], 25.4% of the patients
had an unacceptable HbA1c level of >8%, 39.3% fell into
the suboptimal category with HbA1c level of 7.1-8.0%,
22.8% had an optimal HbA1c level of 6.5-7.0%, and
12.2% of patients had an ideal HbA1c level of 4.5-6.5%.
Patient characteristics
Patient demographic characteristics are presented in
Table 1. Among the patients recruited, the mean age was
62.2 (±11.1) years old and 64% of the patients were 60
years of age and above. Slightly more than half the pa-
tients were female (56.0%). Majority of patients were
Chinese (73.3%). The percentage of Indian patients was
11.6%, disproportionally higher than the national level of
Table 1 Patient demographic characteristics
Characteristics HbA1c ≤ 8.0% HbA1c > 8% Total p-value
(n = 513) (n = 175) (n = 688)*
N (%) N (%) N (%)
Gender
Male 226 (44.2) 76 (43.4) 302 (44.0) 0.854
Female 285 (55.8) 99 (56.6) 384 (56.0)
Age, mean (standard deviation), year 65. 0 (11.4) 58.3 (10.1) 62.2 (11.1) <0.001
Age group
<60 years 156 (30.7) 90 (51.4) 246 (36.0) <0.001
60-69 years 187 (36.8) 49 (28.0) 236 (34.6)
≥ 70 years 165 (32.5) 36 (20.6) 201 (29.4)
Ethnicity
Chinese 390 (76.0) 114 (65.1) 504 (73.3) 0.023
Malay 55 (10.7) 27 (15.4) 82 (11.9)
Indian 51 (9.9) 29 (16.6) 80 (11.6)
Others 17 (3.3) 5 (2.9) 22 (3.2)
Marital status
Married 455 (88.7) 137 (78.3) 592 (86.1) 0.002
Single 35 (6.8) 20 (11.4) 55 (8.0)
Others 23 (4.5) 18 (10.3) 41 (6.0)
P-value from Chi-square test; deviation from the grand total is due to missing data.
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mellitus in the ethnic Indian group.
Patient socio-economic characteristics are presented in
Table 2. More than 90% of the patients lived in public Hous-
ing and Development Board (HDB) flats, which is higher
than that of the national population which is 84% [14]. Of
those who provided their household income information,
more than one third had monthly household income below
S$2000, but this information should be interpreted with
caution as almost one third of the interviewees’ household
income was not reported. A substantial percentage of the
patients (90%) had not obtained tertiary education.
Patient diabetic disease characteristics are presented in
Table 3. Three-quarters (74.6%) of the patients were over-
weight or obese. Oral hypoglycaemic medication was the
predominant regimen with 92.7% of patients receiving this
treatment. Most of the patients (88.7%) complied with
diabetes treatment most or all of the time. The most
common co-morbidities in these diabetic patients are
hypertension and hypercholesterolemia. Complications
reported in this group of patients were micro-vascular
conditions, including peripheral neuropathy (24.0%), ret-
inopathy (24.5%), and kidney disease (7.7%), as well as
macro-vascular conditions, including ischemic heart dis-
ease (13.9%), stroke (7.9%), and peripheral vascular disease
(5.7%). It is interesting to note that over 90% of the pa-
tients were satisfied with the clinic management and were
confident in their doctor.Bivariate logistic regression analysis
Associations between patient characteristics and un-
acceptable HbA1c control (>8%) by logistic regression ana-
lyses are presented in Table 4. The proportion of patients
with unacceptable HbA1c control was highest in the youn-
ger patient group (<60 years old) (36.6%) compared to the
older patients groups (20.8% and 17.9%, respective). In bi-
variate logistic regression analysis, younger age is signifi-
cantly associated with unacceptable HbA1c control, with
the OR being 0.45 and 0.38 respectively for the age bands
of 60 to 69 years and 70 years and above, as compared to
<60 years old. Within individual ethnic groups, a larger
proportion of Malay (32.9%) and Indian (36.3%) diabetic
patients had unacceptable HbA1c control in comparison
to Chinese diabetes patients (22.7%). The ORs (95% CI) of
having unacceptable HbA1c control for Malay and Indian
versus Chinese patients were 1.68 (1.01 to 2.78) and 1.94
(1.18 to 3.20), respectively.
The proportion of patients with unacceptable HbA1c
control increased with the duration of diabetes in the
studied patient population. The proportion was 22.2% in
patients with less than 10 years of DM history, but in-
creased to 29.4% in patients with 10 or more years of DM
history. The OR of having unacceptable HbA1c control for
patients with ≥ 10 years of DM versus those had DM
for <10 years was 1.47 (95% CI: 1.04 to 2.08).
Differences in the percentage of patients with unaccept-
able HbA1c control in terms of different treatment
Table 2 Patient socio-economic characteristics
Characteristics HbA1c ≤ 8.0% HbA1c > 8% Total p-value
(n = 513) (n = 175) (n = 688)
N (%) N (%) N (%)
Occupation
Retired 198 (38.6) 42 (24.0) 240 (34.9) 0.001
Employed 160 (31.2) 78 (44.6) 238 (34.6)
Unemployed 17 (3.3) 9 (5.1) 26 (3.8)
Housewife 123 (24.0) 44 (25.1) 167 (24.3)
Others 15 (2.9) 2 (1.1) 17 (2.5)
Housing type
Public housing 1–2 rooms 46 (9.1) 43 (7.4) 59 (8.7) <0.001
Public housing 3 rooms 94 (18.5) 62 (35.4) 156 (22.9)
Public housing 4 rooms 176 (34.7) 53 (30.3) 229 (33.6)
Public housing 5 rooms or EC 152 (30.0) 30 (17.1) 182 (26.7)
Private condominium / Landed property 39 (7.7) 17 (9.7) 56 (8.2)
Household income
SGD < $1000 115 (22.8) 34 (19.7) 149 (22.0) 0.333
SGD $1000-$1999 72 (14.3) 32 (18.5) 104 (15.3)
SGD $2000-$3999 82 (16.2) 35 (20.2) 117 (17.3)
SGD $4000-$5999 35 (6.9) 15 (8.7) 50 (7.4)
SGD≥ $6000 39 (7.7) 9 (5.2) 48 (7.1)
Refuse to disclose/Unknown 162 (32.1) 48 (27.8) 210 (31.0)
Highest education
No formal education 156 (30.7) 50 (28.7) 206 (30.2) 0.792
Primary (PSLE) 142 (27.9) 53 (30.5) 195 (28.6)
Secondary (O/N level) 130 (25.5) 43 (24.7) 173 (25.3)
Post-secondary (A level) 25 (4.9) 5 (2.9) 30 (4.4)
Post-secondary (ITE/NTC) 9 (1.8) 3 (1.7) 12 (1.8)
Tertiary (Diploma/Degree) 47 (9.2) 20 (11.5) 67 (9.8)
P-value from Chi-square test; deviation from the grand total is due to missing data.
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ceiving insulin (53.4%) and lower in the patients who were
not on insulin (22.1%). The risk was also significantly
higher in the insulin patient group with OR of 4.03 (95%
CI: 2.45 to 6.62), showing the treatment regimens corre-
sponding to the severity of disease.
Patient’s compliance to medication treatment is critical in
the management of diabetes mellitus. A large proportion of
patients (54.3%) whose self-reported compliance to medica-
tion was less optimal had unacceptable HbA1c control than
patients (24.1%) who at least complied with medication
treatment most of the time. The OR of having unacceptable
HbA1c control was 3.59 (95% CI: 1.80 to 7.51) for patients
who had suboptimal compliance to medication as com-
pared to patients who complied with medication treatment.
Obesity is a major risk factor for developing diabetes
mellitus in adults. In the study population, more obesepatients (30.0%) had unacceptable HbA1c control com-
pared to diabetes patients with normal BMI (20.7%) and
the OR of unacceptable HbA1c control for obesity versus
normal weight was 2.25 (95% CI: 1.40- 3.61).
Patients who were not married, living in smaller public
housing flats (≤3 rooms), or carrying out self-glucose
monitoring at home were also more likely to have un-
acceptable glycaemic control. Other factors, such as gen-
der, smoking history, household income, education level,
satisfaction with clinic and confidence on the doctor were
not associated with unacceptable HbA1c control.
Multivariate logistic regression analysis
Multivariate logistic regression analysis is presented in
Table 4. Statistically significant variables associated with
unacceptable HbA1c control identified from the bivariate
logistic regression analyses and well known confounding
Table 3 Patient diabetic disease characteristics
Characteristics HbA1c ≤ 8.0% HbA1c > 8% Total p-value
(n = 513) (n = 175) (n = 688)
N (%) N (%) N (%)
BMI
<23 kg/m2 131 (27.0) 34 (20.9) 165 (25.4) <0.001
23-27.4 kg/m2 228 (47.0) 55 (33.7) 283 (43.7)
≥27.5 kg/m2 126 (26.0) 74 (45.4) 200 (30.9)
Smoking status
Never smoker 355 (69.5) 125 (71.8) 480 (70.1) 0.438
Ex-smoker 104 (20.4) 37 (21.3) 141 (20.6)
Current smoker 52 (10.2) 12 (6.9) 64 (9.3)
Duration of DM
Less than 5 years 177 (34.6) 48 (27.4) 225 (32.8) 0.154
5-9.9 years 113 (22.1) 35 (20.0) 148 (21.6)
10-14.9 years 89 (17.4) 31 (17.7) 120 (17.5)
15-19.9 years 43 (8.4) 23 (13.1) 66 (9.6)
20 years or above 89 (17.4) 38 (21.7) 127 (18.5)
DM treatment*
Insulin 34 (6.8) 39 (22.7) 73 (10.8) <0.001
Medication 467 (91.6) 167 (96.0) 634 (92.7) 0.054
Diet controls 428 (84.4) 140 (80.5) 568 (83.4) 0.226
Exercise 314 (61.9) 106 (61.3) 420 (61.8) 0.877
Compliance to medication
All the time 381 (74.6) 121 (69.1) 502 (73.2) 0.001
Most of the time 76 (14.9) 30 (17.1) 106 (15.5)
Sometimes 15 (2.9) 17 (9.7) 32 (4.7)
Rarely 0 1 (0.6) 1 (0.2)
Never 1 (0.2) 1 (0.6) 2 (0.3)
No medication is needed 38 (7.4) 5 (2.9) 43 (6.3)
DM-related co-morbidities*
Stroke 44 (8.6) 10 (5.8) 54 (7.9) 0.226
Ischaemic heart disease 75 (14.7) 20 (11.6) 95 (13.9) 0.302
Kidney disease 38 (7.4) 15 (8.6) 53 (7.7) 0.614
Peripheral neuropathy 122 (23.9) 42 (24.3) 164 (24.0) 0.925
Retinopathy 116 (22.8) 51 (29.7) 167 (24.5) 0.069
Peripheral vascular disease 26 (5.1) 13 (7.5) 39 (5.7) 0.249
Any of DM-related diseases 255 (49.9) 92 (52.9) 347 (50.7) 0.498
Self-monitoring at home 133 (26.0) 60 (34.5) 193 (28.2) 0.032
Chronic medical problems
Hypertension 369 (72.2) 107 (61.5) 476 (69.5) 0.008
Hypercholesterolemia 367 (71.8) 125 (71.8) 492 (71.8) 0.996
History of cancer 21 (4.1) 8 (4.6) 29 (4.3) 0.790
Arthritis 163 (32.0) 51 (29.3) 214 (31.3) 0.515
Asthma 33 (6.5) 10 (5.8) 43 (6.3) 0.751
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Table 3 Patient diabetic disease characteristics (Continued)
Lung disease 16 (3.1) 3 (1.7) 19 (2.8) 0.337
Liver disease 20 (3.9) 7 (4.1) 27 (4.0) 0.938
Mental disorders 26 (5.1) 6 (3.5) 32 (4.7) 0.383
Urology problems 53 (10.4) 14 (8.1) 67 (9.8) 0.383
ENT problems 45 (8.8) 10 (5.8) 55 (8.1) 0.210
Any of chronic medical problems 474 (92.8) 150 (86.2) 624 (91.1) 0.009
Management satisfaction by clinic
Not satisfied 9 (1.8) 4 (2.3) 13 (1.9) 0.151
A little 35 (6.9) 21 (12.0) 56 (8.1)
Mostly 297 (58.4) 91 (52.0) 388 (56.7)
Very satisfied 168 (33.0) 59 (33.7) 227 (33.2)
Confidence in doctor
Not confident 5 (1.0) 1 (0.6) 6 (0.9) 0.280
A little 39 (7.7) 20 (11.5) 59 (8.6)
Mostly 288 (56.6) 87 (50.0) 375 (54.9)
Very confident 177 (34.8) 66 (37.9) 243 (35.6)
P-value from Chi-square test; deviation from the grand total is due to missing data.
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ethnicity were included in the multivariate logistic regres-
sion model. The other variables included marital status,
occupation status, housing type, duration of diabetes, type
of diabetes treatment, compliance to medication treat-
ment, BMI, and self-monitoring of glucose at home. All
complications and co-morbidities were not significant in
the bivariate logistic regression analysis, including hyper-
tension, hypercholesterolemia, stroke, ischemic heart dis-
ease, kidney disease, peripheral neuropathy, retinopathy,
and peripheral vascular disease, and have not been in-
cluded in Table 4.
In this analysis, statistical significance was observed for
age older than 60 years old versus <60 years old (OR =
0.42 for 60–69 years [95% CI: 0.25 to 0.73] and 0.38
for ≥70 years [95% CI: 0.20 to 0.73]) , living in larger hous-
ing versus 1–3 room public housing (OR = 0.52, 95% CI:
0.33 to 0.80), ≥10 years of diabetes history versus <10
years of DM (OR = 1.73, 95% CI: 1.11 to 2.71) , presence
versus absence of insulin treatment for diabetic control
(OR = 2.68, 95% CI: 1.45 to 4.95), and poor versus good
compliance to medication (OR = 3.72, 95% CI: 1.55 to
7.64). Not being married and obesity were borderline sig-
nificantly associated with unacceptable glycaemic control.
Discussion
In our study, the mean HbA1c level was 7.6% and the me-
dian HbA1c was 7.3%, and 25.4% of patients had an un-
acceptable HbA1c (>8%). This result is comparable with
studies conducted in the US [15] where the mean HbA1c
was 7.6% and 37.1% had HbA1c >8%, as well as in
Australia [16] where 24.3% of patients had HbA1c equalor more than 8.0%. A study conducted in another local
polyclinic in 2003 [7] observed a mean HbA1c of 8.3%,
while the Chronic disease management plan (CDMP)
2007 in Singapore showed that 31.1% of patients had
HbA1c >8% [17].
Younger patients (<60 years old) in our study had
poorer glycaemic control. In the literature, the evidence
for the association between age and glycaemic control in
type 2 diabetic patients is mixed. Some studies have found
that glycaemic control is better in younger patients [18],
while others have shown no effect [19,20]. Several studies
in Singapore [7], United States [21,22], Netherlands [6]
and Germany [23] have similar findings with our study,
which have also shown that younger patients have poorer
glycaemic control.
Recent evidence suggests that early-onset type 2 dia-
betes mellitus is a more aggressive disease phenotype than
the later-onset cohort, and these early-onset diabetics ex-
perience high complication burden [24].
Health is a value, and to some it may not be the highest
value [25]. Younger adult patients may be less motivated
to manage their diabetic condition, as they may be busy
with their job, and have less time to comply with a healthy
lifestyle, medication and clinic visits. A patient with early
diabetes prior to the onset of complications and asymp-
tomatic, in whom the quality of life has not yet been af-
fected, may not perceive the need for good diabetic
control [12].
In our study, we have also analyzed the characteristics
peculiar to the younger group of diabetic patients that
could have contributed to the poorer control. Younger
adult diabetics were more likely to be employed,
Table 4 Associations between patient characteristics by HbA1c levels by logistic regression analyses in type 2 diabetes
mellitus patients treated and followed up in SingHealth polyclinics
Variables HbA1c Unadjusted OR (95% CI) Adjusted OR (95% CI)‡
≤8.0% ≤8.0%
N (%) N (%)
Gender
Male 226 (74.2) 76 (25.8) 1.00 (ref) 1.00 (ref)
Female 285 (74.8) 99 (25.8) 1.03 (0.73-1.46) 1.20 (0.75-1.92)
Age group
<60 years 156 (63.4) 90 (36.6) 1.00 (ref) 1.00 (ref)
60-69 years 187 (79.2) 49 (20.8) 0.45 (0.30-0.68)*** 0.42 (0.25-0.73)**
≥ 70 years 165 (82.1) 36 (17.9) 0.38 (0.24-0.59)*** 0.38 (0.20-0.73)**
Ethnicity
Chinese 390 (77.4) 114 (22.6) 1.00 (ref) 1.00 (ref)
Malay 55 (67.1) 27 (32.9) 1.68 (1.01-2.78)* 1.02 (0.56-1.88)
Indian 51 (63.8) 29 (36.3) 1.94 (1.18-3.20)** 1.33 (0.72-2.45)
Others 17 (77.3) 5 (22.7) 1.00 (0.36-2.78) 0.50 (0.13-1.92)
Marital status
Not married 58 (60.4) 38 (39.6) 1.00 (ref) 1.00 (ref)
Married 455 (76.9) 137 (23.1) 0.46 (0.29-0.72)*** 0.59 (0.32-1.03)
Smoking status
Never smoker 355 (74.0) 125 (26.0) 1.00 (ref) /
Ex-smoker 104 (73.8) 37 (26.2) 1.01 (0.66-1.55) /
Current smoker 52 (81.3) 12 (18.8) 0.66 (0.34-1.27) /
Occupation
Employed 160 (67.2) 78 (32.8) 1.00 (ref) 1.00 (ref)
Retired/Unemployed 215 (80.8) 51 (19.2) 0.49 (0.32-0.73)*** 0.65 (0.36-1.16)
Housewife/Others 138 (75.0) 46 (25.0) 0.68 (0.44-1.05) 0.81 (0.43-1.49)
Housing type
Public housing 1-3rooms 140 (65.1) 75 (34.9) 1.00 (ref) 1.00 (ref)
Public housing 4–5 rooms/Private 367 (78.6) 100 (21.4) 0.51 (0.36-0.73)*** 0.52 (0.33-0.80)**
Household income
SGD < $4000 269 (72.7) 101 (27.3) 1.00 (ref) /
SGD≥ $4000 74 (75.5) 24 (24.5) 0.86 (0.52-1.44) /
Highest education
No formal education 156 (75.7) 50 (24.3) 1.00 (ref) /
PSLE/O/N level 272 (73.9) 96 (26.1) 1.10 (0.74-1.63) /
A level/ITE/Tertiary 81 (74.3) 28 (25.7) 1.08 (0.63-1.84) /
Duration of DM
Less than 10 years 290 (77.8) 83 (22.2) 1.00 (ref) 1.00 (ref)
10 years or above 221 (70.6) 92 (29.4) 1.47 (1.04-2.08)* 1.73 (1.11-2.71)*
DM treatment
Non-insulin 468 (77.9) 133 (22.1) 1.00 (ref) 1.00 (ref)
Insulin 34 (46.6) 39 (53.4) 4.03 (2.45-6.62)*** 2.68 (1.45-4.95)**
Compliance to medication
All the time/most of time 455 (75.1) 151 (24.9) 1.00 (ref) 1.00 (ref)
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Table 4 Associations between patient characteristics by HbA1c levels by logistic regression analyses in type 2 diabetes
mellitus patients treated and followed up in SingHealth polyclinics (Continued)
Less than all the time 16 (45.7) 19 (54.3) 3.59 (1.80-7.51)*** 3.72 (1.55-7.64)***
Self-monitoring
No 378 (76.8) 114 (23.2) 1.00 (ref) 1.00 (ref)
Yes 133 (68.9) 60 (31.1) 1.50 (1.03-2.17)* 1.27 (0.79-2.02)
BMI
<23 kg/m2 130 (79.3) 34 (20.7) 1.00 (ref) 1.00 (ref)
23-27.4 kg/m2 227 (80.5) 55 (19.5) 0.93 (0.57-1.50) 0.91 (0.53-1.55)
≥27.5 kg/m2 173 (70.0) 74 (30.0) 2.25 (1.40-3.61)*** 1.78 (1.01-3.13)
Management satisfaction by clinic
Very satisfied 168 (74.0) 59 (26.0) 1.00 (ref) /
Mostly 297 (76.6) 91 (23.5) 0.87 (0.60-1.27) /
Not satisfied/A little 44 (63.8) 25 (36.2) 1.62 (0.91-2.87) /
Confidence in doctor
Very confident 177 (72.8) 66 (27.2) 1.00 (ref) /
Mostly 288 (76.8) 87 (23.2) 0.81 (0.56-1.17) /
A little/Not confident 44 (67.7) 21 (32.3) 1.28 (0.71-2.31) /
*P-value < 0.05; **p-value < 0.01; ***p-value < 0.001.
‡Multivariate logistic regression model, adjusted for age (<60, 60–69, ≥70 years), gender (male, female), race (Chinese, Malay, Indian, Others), marital status
(married, single, others), occupation (employed, retired/unemployed, housewife/others), housing type (public1-4, public5/private), BMI (<23, 23–27.5, >27.5),
duration of DM (<10, ≥10 years), DM treatment (non-insulin, insulin), compliance to medication (all the time, less than most of time), monitor glucose at home
(yes, no).
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smoking, less confident in their doctor, and less adherent
to medication were also younger. This is of public health
importance, and targeting their lifestyle and behavioural
factors could be the key to better glycaemic control in this
group of patients.
Effective educational and behaviour modification pro-
grammes would be required to target younger diabetics,
as this group with earlier disease onset may have a longer
life expectancy relevant to prevention of complications.
Evidence has shown that good glycaemic control may be
beneficial especially earlier in the disease course [26], and
benefits emerge in the long term [27]. This phenomenon
presents major governmental, societal, cultural, public
health and medical challenges to promote healthy lifestyle
in the early years and to administer timely optimized med-
ical care to prevent or reduce the onset of complications
in these diabetic patients.
Longer duration of diabetes was associated with poorer
HbA1c control. This observation is consistent with other
studies [6,21]. This reflects the natural progression of type
2 diabetes mellitus due to progressive pancreatic beta cell
failure.
Patients using insulin in their treatment regimen had a
higher rate of suboptimal glycaemic control (53.4%) com-
pared to patients without insulin treatment (22.1%). This
finding is consistent with other studies [7,20,24]. This ob-
servation is likely due to the fact that in the currentguidelines, the indication for starting patients on insulin is
when their diabetic control is not optimally controlled by
oral medication, and hence these patients on insulin are
patients with advanced diabetes where good glycae-
mic control is less likely to be achieved. Difficulty of
maintaining glycaemic control while minimizing hypo-
glycemia, weight gain as an anabolic effect of insulin, and
non-compliance with diet, can also contribute to poorer
control with insulin.
Being unmarried, as well as obesity, were borderline sig-
nificantly associated with unacceptable diabetic control. A
stable life partner could potentially provide a strong social
and emotional support for a patient with chronic disease
like diabetes, to aid the patient in maintaining a healthy
lifestyle and compliance to treatment. Obesity is also a
well-known factor associated with poorer glycaemic con-
trol [28].
Our study demonstrated that better self-reported com-
pliance to medication treatment is associated with better
HbA1c control. This knowledge is beneficial for the
healthcare provider and patients in diabetes management
to encourage adherence to therapy.
The strengths of the study include: this study was the
first large scale study conducted for type 2 diabetes pa-
tients who are treated and followed up in all SingHealth
Polyclinics; patient recruitment was conducted in eight
SingHealth Polyclinics with response rate of 72.5% which
is reasonable for survey studies; the study population is
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ment in the polyclinics; the study captured a broad range
of data which provide an important insight into possible
predictors associated with poor glycaemic control in dia-
betes patients in primary care.
The limitations in this study include: firstly, the cross-
sectional study would not be able to establish causal-effect
relationship of the significant factors identified. Secondly,
all variables other than HbA1c were based on self-re-
porting. There were no methods in place to verify the
accuracy or reliability of the data collected through ques-
tionnaire survey.
Increased attention should be paid to patients who are
younger, patients who have had longer diabetes history,
patients who are on insulin therapy and patients who
are less compliant to medication treatment. The chal-
lenge is to develop the most effective strategy to con-
tinually enhance diabetes management for our diabetic
patients in primary care.
Conclusions
Treating type 2 diabetic patients to target is an ongoing
challenge. Younger adult patients were found to have
poorer glycaemic control, and hence targeted educational
and behaviour modification programmes would be re-
quired to effectively manage this group of younger
diabetics.
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